Fulgent Genetics Inc (FLGT)
Operating profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | -73,918 | -88,670 | -71,377 | -72,269 | -75,295 | -80,986 | -80,638 | -42,254 | 184,503 | 371,941 | 530,652 | 610,964 | 675,953 | 751,002 | 655,252 | 558,994 | 290,158 | 63,840 | 1,826 | -519 |
| Revenue (ttm) | US$ in thousands | 283,470 | 277,761 | 290,705 | 287,530 | 289,213 | 286,412 | 307,380 | 364,868 | 618,968 | 802,935 | 925,148 | 953,423 | 992,584 | 1,035,891 | 909,739 | 773,388 | 421,712 | 135,121 | 43,752 | 34,911 |
| Operating profit margin | -26.08% | -31.92% | -24.55% | -25.13% | -26.03% | -28.28% | -26.23% | -11.58% | 29.81% | 46.32% | 57.36% | 64.08% | 68.10% | 72.50% | 72.03% | 72.28% | 68.80% | 47.25% | 4.17% | -1.49% |
December 31, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-73,918K ÷ $283,470K
= -26.08%
Fulgent Genetics Inc's operating profit margin has shown significant fluctuations over the reporting periods provided. The operating profit margin started at a negative 1.49% in March 2020, indicating the company was incurring losses from its operations. However, by December 2021, the operating profit margin had improved significantly to 68.10%, reflecting a strong ability to generate profits from its core business activities.
From March 2022 to June 2023, the operating profit margin remained relatively high, staying above 50%. However, from September 2023 onwards, the operating profit margin started to decline, turning negative by March 2024. This downward trend continued until December 2024, reaching a low of -26.08%.
The decreasing trend in the operating profit margin suggests potential challenges in managing costs or generating sufficient revenue to cover operating expenses. It is essential for Fulgent Genetics Inc to closely monitor its operational efficiency and profitability to address the declining trend in the operating profit margin and work towards improving its financial performance.
Peer comparison
Dec 31, 2024